AzTrials
AzTrials

AgingARECOVIDNCT04993573

Acceptability, Representations and Experiences of the COVID-19 Pandemic

An observational study of Aging, run by Centre Hospitalier Universitaire de Saint Etienne at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The "ARECOVID" project is a comprehensive sociological study of what is being played out in organizational terms in the face of the COVID-19 pandemic. Through quantitative methods (questionnaires) and qualitative methods (semi-directive interviews), we would understand the essential views of the populations concerned… Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Aging
What is being tested?
Questionnaire and Individual interview
How many people
520 participants
Where
1 siteFrance
Study dates
1 Jul 2020to 30 Jul 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Older 65 people Caregivers who works in gerontology

Who may be able to join

  • For older people : minimum age : 65 years
  • For caregivers : works in gerontology

Who cannot join

  • Person with a neurological disease
  • Person under guardianship or curatorship

Trial locations and contacts

1 site in 1 country.

France1 site
  • Gérontopole AURA

    Saint-Etienne

Other trials in France

About this study

Official title: Acceptability, Representations and Experiences of the COVID-19 Pandemic : the ARECOVID Project

The "ARECOVID" project is a comprehensive sociological study of what is being played out in organizational terms in the face of the COVID-19 pandemic. Through quantitative methods (questionnaires) and qualitative methods (semi-directive interviews), we would understand the essential views of the populations concerned by COVID-19, but also that of actors taking care of vulnerable elderly non-COVID. Special attention will be paid to the care pathway of elderly people with and without the virus, in a health system in full reorganization. We will try to understand the needs and experiences of all health actors (hospital/city) involved in COVID-19 and the experience of confinement and the Covid-19 of the elderly living at home, in order to reflect on a possible improvement in the health response of elderly people in the event of an epidemic health crisis.

Read the detailed description

understand the needs and experiences of all health actors (hospital/city) involved in COVID-19 and the experience of confinement and the Covid-19 of the elderly living at home

Conditions
Aging
Being tested
Questionnaire, Individual interview
Keywords
COVID-19, caregivers, older, ageism, public health, hospital
Medical subject headings
COVID-19, Ageism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QuestionnaireOther

    Questions about the impact of COVID-19 in their works

  • Individual interviewOther

    Discussion between the searcher and the participant about representations of COVID-19 and experiences about confinement.

Study groups in NCT04993573
Study groupRoleWhat they receive
CaregiversCaregivers who work with older patients will be included. They will have a questionnaire
Receives: Other: Questionnaire
OlderOlder 65 people who live alone in their house will be included. They will have Individual interviews.
Receives: Other: Individual interview

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Analysis representations of COVID-19 and confinement of older people

    Measure by individual interviews

    Measured: Day 20

Secondary outcomes (1)
  1. Analysis impacts of COVID-19 in works of caregivers

    Measure by questionnaire

    Measured: Day 20

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Aug 2021
  2. Study start1 Jul 2020
  3. Primary completion30 Jul 2020
  4. Study completion30 Jul 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
520 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04993573
Sponsor's protocol ID
GA-2021-02
Acronym
ARECOVID
Status last verified
Aug 2021
First submitted
5 Aug 2021
Last updated
6 Aug 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Aging, run by Centre Hospitalier Universitaire de Saint Etienne at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Analysis representations of COVID-19 and confinement of older people (time frame: Day 20). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in